These reports do demonstrate that long-term mTOR inhibitors are generally well tolerated, and the most frequent adverse events were mild-to-moderate headache, fatigue, hypercholesterolemia and mucositis (27–30). This evidence concerns the gene MTOR and familial hypercholesterolemia.